Nationals from Colombia and Peru apply for asylum in the EU+ in record numbers
The monthly total of applications for international protection remains relatively stable.
In May 2019, the monthly number of applications for international protection lodged in the 30 EU+ countries (European Union Member States plus Norway and Switzerland) remained stable at around 57 000. However since the start of the year, some 287 500 applications have been lodged, which is 14 % more than in the same period last year.
The ten main citizenships of origin of applicants in May were Syria, Afghanistan, Venezuela, Iraq, Colombia, Nigeria, Pakistan, Iran, Turkey and Georgia. The most notable rising trend was for Colombian nationals, with 2 800 applications reaching the highest values in the past few years. Be it with smaller absolute numbers, a record level was also reached for Peruvian applications.
After a dip in April, in May there was again a 7 % increase in the number of first-instance decisions issued in the EU+, reaching 47 275. The recognition rate dropped slightly to 32 % in May, or 35 % when combining decision-data for the six-month period ending in May. The highest six-month recognition rates were for citizens from Yemen (89 %), Syria (87 %) and Eritrea (80 %) and the lowest for nationals from Moldova (0.4 %), North Macedonia (1 %), Georgia and India (each 3 %).
At the end of May, the number of cases awaiting a first-instance decision was stable with some 445 000 cases. Compared to the same month of last year, the stock went up by 16 300.
For more information and an interactive data-visualisation, please visit the Latest Asylum Trends page.
Latest News from
EC opens investigation into possible anti-competitive conduct of Amazon18/07/2019 15:25:00
The EC has opened a formal antitrust investigation to assess whether Amazon's use of sensitive data from independent retailers who sell on its marketplace is in breach of EU competition rules.
Turkish drilling activities in the Eastern Mediterranean16/07/2019 15:25:00
The Council adopted the following conclusions on the Turkish drilling activities in the Eastern Mediterranean.
Four new substances added to the Candidate List16/07/2019 13:43:00
The Candidate List of substances of very high concern (SVHCs) for authorisation now contains 201 substances.
Imports of hormone-free beef: EU-US agreement confirmed16/07/2019 11:43:00
The Council has adopted a decision on the signing of an agreement between the EU and the US on the allocation to the US of a share in the TRQ for high quality beef regarding the importation of beef from animals not treated with certain growth-promoting hormones.
EIOPA consults on the harmonisation of national insurance guarantee schemes15/07/2019 12:32:00
Tthe European Insurance and Occupational Pension Authority (EIOPA) has launched a consultation on its Advice on the harmonisation of national insurance guarantee schemes across the Member States of the European Union.
EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals12/07/2019 15:25:00
The EU and the USA have delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
Airbnb cooperates with EC and EU consumer authorities improving the way it presents offers12/07/2019 13:25:00
The EC has announced that, as a result of negotiations with Airbnb, the platform has improved and fully clarified the way it presents accommodation offers to consumers, which is now in line with the standards set in EU consumer law.
European Institute of Innovation and Technology: EC proposes strategy for 2021-202712/07/2019 11:33:00
The EC has proposed an update of the legal base of the European Institute of Innovation and Technology (EIT) as well as its new Strategic Innovation Agenda for 2021-2027.
EC approves GlaxoSmithKline's acquisition of Pfizer's Consumer Health Business with conditions11/07/2019 15:25:00
The EC has approved, under the EU Merger Regulation, the acquisition of Pfizer's Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer's topical pain management business carried out under the ThermaCare brand.